S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Aequus Pharmaceuticals Inc. (AQS.V) Stock Forecast, Price & News

+0.02 (+12.50 %)
(As of 01/15/2021 03:59 PM ET)
Today's Range
Now: C$0.14
50-Day Range
MA: C$0.10
52-Week Range
Now: C$0.14
Volume659,201 shs
Average Volume312,811 shs
Market CapitalizationC$15.08 million
P/E RatioN/A
Dividend YieldN/A
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistita, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; Mynosys Cellular Devices for distribution, sales and marketing of Zepto for cataract surgery; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was founded in 2013 and is headquartered in Vancouver, Canada.


Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesC$2.28 million
Cash FlowC$0.03 per share
Book ValueC$0.01 per share



Market CapC$15.08 million
Next Earnings Date5/5/2021 (Estimated)
OptionableNot Optionable
+0.02 (+12.50 %)
(As of 01/15/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQS News and Ratings via Email

Sign-up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aequus Pharmaceuticals Inc. (AQS.V) (CVE:AQS) Frequently Asked Questions

How has Aequus Pharmaceuticals Inc. (AQS.V)'s stock price been impacted by Coronavirus?

Aequus Pharmaceuticals Inc. (AQS.V)'s stock was trading at C$0.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AQS stock has increased by 22.7% and is now trading at C$0.14.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Aequus Pharmaceuticals Inc. (AQS.V)?

Wall Street analysts have given Aequus Pharmaceuticals Inc. (AQS.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aequus Pharmaceuticals Inc. (AQS.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Aequus Pharmaceuticals Inc. (AQS.V)'s next earnings date?

Aequus Pharmaceuticals Inc. (AQS.V) is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Aequus Pharmaceuticals Inc. (AQS.V)

Who are some of Aequus Pharmaceuticals Inc. (AQS.V)'s key competitors?

What other stocks do shareholders of Aequus Pharmaceuticals Inc. (AQS.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aequus Pharmaceuticals Inc. (AQS.V) investors own include GrowLife (PHOT), Terra Tech (TRTC), Abbott Laboratories (ABT), Acorn Energy (ACFN), Crown Castle International (CCI), Charlotte's Web (CWBHF), (FIRE.V) (FIRE), LiCo Energy Metals (LIC), Marijuana Company of America (MCOA) and Planet 13 (PLNHF).

Who are Aequus Pharmaceuticals Inc. (AQS.V)'s key executives?

Aequus Pharmaceuticals Inc. (AQS.V)'s management team includes the following people:
  • Mr. Douglas Glen Janzen, Chairman, CEO & Pres (Age 51, Pay $191.25k)
  • Ms. Ann Fehr CGA, CPA, Chief Financial Officer (Age 51, Pay $123.95k)
  • Ms. Anne Michelle Stevens M.H.A., B.Sc., BSc, MHA, Corp. Sec. & Director (Age 39, Pay $142.97k)
  • Mr. Stuart Fowler, Strategic Commercial Advisor & Independent Director
  • Mr. Grant Larsen, Chief Commercial Officer

What is Aequus Pharmaceuticals Inc. (AQS.V)'s stock symbol?

Aequus Pharmaceuticals Inc. (AQS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "AQS."

How do I buy shares of Aequus Pharmaceuticals Inc. (AQS.V)?

Shares of AQS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Aequus Pharmaceuticals Inc. (AQS.V)'s stock price today?

One share of AQS stock can currently be purchased for approximately C$0.14.

How big of a company is Aequus Pharmaceuticals Inc. (AQS.V)?

Aequus Pharmaceuticals Inc. (AQS.V) has a market capitalization of C$15.08 million and generates C$2.28 million in revenue each year. Aequus Pharmaceuticals Inc. (AQS.V) employs 10 workers across the globe.

What is Aequus Pharmaceuticals Inc. (AQS.V)'s official website?

The official website for Aequus Pharmaceuticals Inc. (AQS.V) is www.aequuspharma.ca.

How can I contact Aequus Pharmaceuticals Inc. (AQS.V)?

Aequus Pharmaceuticals Inc. (AQS.V)'s mailing address is 2820-200 Granville St, VANCOUVER, BC V6C 1S4, Canada. The company can be reached via phone at +1-604-3367906.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.